Paolo Tarantino shared a post on X:
“It feels like yesterday when I first stepped into Dana-Farber Cancer Institute to start my research fellowship at Dana-Farber’s Breast Oncology Center.
Yet here I am, three years later, reflecting on how much support, inspiration, mentorship, opportunities and friends I found in this place. Incredibly grateful.”
Source: Paolo Tarantion/X
More posts featuring Paolo Tarantino on oncodaily.com
Dr. Paolo Tarantino, MD, is pursuing an advanced research fellowship at Dana-Farber Cancer Institute and Harvard Medical School, concurrently working towards a PhD in clinical research at the University of Milan.
His research focuses on exploring the HER2 oncoprotein, investigating the emerging HER2-low subgroup of breast tumors, and developing novel antibody-drug conjugates targeting every subtype of breast cancer. With a publication record exceeding 50 papers on breast cancer, he is recognized as a leading expert in the field.